MedPath

Caffeine's Effect on Attention

Not Applicable
Completed
Conditions
Attention
Registration Number
NCT02264561
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

The purpose of this study is to determine whether caffeine improves attention.

Detailed Description

Single centre single dose cross-over, placebo-controlled, double blind, randomized trial with two treatment conditions : caffeine and placebo

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Attention test: milliseconds and index of stimulus sensitivityduration 10 days from screening to last visit (V2)
Secondary Outcome Measures
NameTimeMethod
Central Nervous System :response time.duration: 10 days from screening to last visit (V2)
Mood measures: Visual Analog scale.duration 10 days from screening to last visit V2

Trial Locations

Locations (1)

Center for Human Drug Research

🇳🇱

Leiden, CL, Netherlands

Center for Human Drug Research
🇳🇱Leiden, CL, Netherlands
© Copyright 2025. All Rights Reserved by MedPath